dc.contributor.author | Slack, Mary | |
dc.contributor.author | Vyse, Andrew | |
dc.contributor.author | Madhava, Harish | |
dc.contributor.author | Reinert, Ralf-Rene | |
dc.contributor.author | Ellsbury, Gillian | |
dc.contributor.author | Czudek, Carole | |
dc.contributor.author | Gessner, Bradford | |
dc.date.accessioned | 2019-10-17T03:34:49Z | |
dc.date.available | 2019-10-17T03:34:49Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 0891-3668 | |
dc.identifier.doi | 10.1097/INF.0000000000002184 | |
dc.identifier.uri | http://hdl.handle.net/10072/388487 | |
dc.description.abstract | To the Editors:
We read with interest the article by Makwana et al.1 The authors note that most childhood invasive pneumococcal disease (IPD) cases are now due to non-13 valent pneumococcal conjugate vaccine (PCV13) serotypes though PCV13 serotypes remain in circulation with serotypes 3 and 19A listed among the top 10 that caused IPD in children in 2015/16. Of the 25 cases with PCV13-type IPD in 2015/16, 11 (44%) were due to serotype 19A. | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Lippincott Williams & Wilkins | |
dc.relation.ispartofpagefrom | 444 | |
dc.relation.ispartofpageto | 444 | |
dc.relation.ispartofissue | 4 | |
dc.relation.ispartofjournal | Pediatric Infectious Disease Journal | |
dc.relation.ispartofvolume | 38 | |
dc.subject.fieldofresearch | Paediatrics and Reproductive Medicine | |
dc.subject.fieldofresearch | Public Health and Health Services | |
dc.subject.fieldofresearchcode | 1114 | |
dc.subject.fieldofresearchcode | 1117 | |
dc.subject.keywords | Science & Technology | |
dc.subject.keywords | Life Sciences & Biomedicine | |
dc.subject.keywords | Immunology | |
dc.subject.keywords | Infectious Diseases | |
dc.title | Ongoing Exposure of UK Infants to Vaccine Serotype Pneumococci | |
dc.type | Journal article | |
dc.type.description | C3 - Articles (Letter/ Note) | |
dcterms.bibliographicCitation | Slack, M; Vyse, A; Madhava, H; Reinert, R-R; Ellsbury, G; Czudek, C; Gessner, B, Ongoing Exposure of UK Infants to Vaccine Serotype Pneumococci, Pediatric Infectious Disease Journal, 2019, 38 (4), pp. 444-444 | |
dc.date.updated | 2019-10-17T03:31:50Z | |
dc.description.version | Accepted Manuscript (AM) | |
gro.rights.copyright | © 2019 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in the Pediatric Infectious Disease Journal, Volume 38 - Issue 4 - p 444. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Slack, Mary P. | |